CLINICAL ROLE -
Overview of PARP Inhibitors in the Treatment of Ovarian Cancer
There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Therapies in the Pipeline for Prostate Cancer
New potential medications may continue to expand the role of targeted agents.
2 Clarke Drive Cranbury, NJ 08512